LIAISON IGF-1 Control - India CDSCO Medical Device Registration

LIAISON IGF-1 Control is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000089_f8d65a5810677fd689acd8e29b003635_3f3abf55ab0ba1126507c715d78118a5. This device is marketed under the brand name LIAISON® EASY System Liquid. The license holder is Diasorin Healthcare India Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class B

LIAISON IGF-1 Control

UID: IMP/IVD/2019/000089_f8d65a5810677fd689acd8e29b003635_3f3abf55ab0ba1126507c715d78118a5

Brand Name

LIAISON® EASY System Liquid

License Holder

Diasorin Healthcare India Pvt. Ltd.

Device Class

Class B

Approving Authority

CDSCO

Product Information

The LIAISON® IGF-I controls (LIAISON® EASY System Liquid) are to be used in LIAISON® chemiluminescent immunoassays (LIAISON® EASY System Liquid) as a means of checking reliability of assay runs. The performance characteristics of LIAISON® IGF-I Control have not been established for any other assays or instrument platforms different from LIAISON® and LIAISON® XL